フィナレビ106号.indb
１ 発病のとき
1 3 2002 11 26 27 5 2003 1 15 16 9 2003 4 16 17 10 2003 6 25 26 12 2003 9 17 13 2003 11 12 13 16 2004 4 21 22 17 2004 5 19 20 18 2004 6 15 17 2004 6 17 20 2004 7 14 15 21 2004 8 18 19 2004 8 19 22 2004
ビ デ オ 教 材 検 索 部
1 2 3 4 5 6 7 8 9 10 11 12 13 3 4 4 4 5 5 5 6 6 6 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 搔 髹 45 WHO 46 47 48 49 50 51 52 53 NHK / / / / / / / / / /
------------------ ------------------ ------------------------------ ------------------------------ ------------------------------ -------------------
CDC TEL FAX ------------------ ------------------ ------------------------------ ------------------------------ ------------------------------ ------------------------------ --------------- ---------------
untitled
() () WHO ICD ICD 19 1 http://www.mhlw.go.jp/toukei/sippei/icd.html ICD-1 1995 7 24 16 ICD-9 1979 54 1994 6 ICD-1 ICD-9 1 1995 24 ICD-1 5+2+2 W1 W3 W1 W13 W17 W23 W24 W51 W52 ICD-1 1 () (1) (2) (3) (4)
QA Q1. A1. 118 2 Q2. A2. Q3. A3. 1) 2) 3) 4) 5) 6) 7) Q4. A4. 024-536-4343 10:0022:00 03-3264-4343 24 2008/10/15 1 1 2 3 2008/10/15 4: 5() N95 6A() SARS WHO B 7B( 1. 2. (( ) 3. 38 4. 5. 6. 2 2008/10/15
untitled
18 12 10 40 H5N1 2005 11 WHO 2005 12 2006 6 (H5N1) 10 25 1,700 ( 1,300 2,500 ) 200 53 64 17 30% 3,785,000 291,200 3 14,100 4 30% 57,600 4,430 3 1,150 320 210 4 2% 0.56% () ) 1 10 2 3A (2B) 3B 4A5A 6A 4B
mediaguide_a4
C O N T E N T S C O N T E N T S Magazine for people who never give up reading Comic! 21.0 70 30 26.3 100 21.0 90 10 18.7 35 65 23.0 90 10 29.1 83 17 20.5 85 15 Magazine for people who never give up reading
(1)
12 3700 730 2 3 1 1 (1) (2) 1 1 1 + (3) ( ) (3) 2 (2) 1. (1) 4 1360 5kg 30 0027 25.1 (500 ) 557 224 1320 4kg(1000 ) 15 0032 40.7 5kg(1000 ) 5 0016 60.5 3kg(500 ) 25 0022 54.6 ( kg700 11/22 8kg ) (2) 40.7
- 1 - A B C D E or or D or or d - 2 - A p18 P19 P21-3 - - 4 - B 2001 P21 P18 P19-5 - - 6 - C P21-7 - - 8 - D P21-9 - P16-10 - E - 11 - RT-PCR - 12 - P16-13 - P21-14 - P16-15 - - 16 - - 17 - Yes No Yes
:00 9:00
15 23 16 16 1 H14.11 21 2 61 3 4 28 27 8:00 9:00 11 15 16 21 QO L YU 13 21 14 21 10 iearn 14 12 13 14 14 14
04菊池氏.indd
KIKUCHI Sakae 1 1 1899 32 2000 1966 1.58 1990 1.57 2000.15 2 32 13 2 3 4 18 39.6 25 216,974 106,594 110,380 12 22 5 4.72 12 6 25 33 60 90 25 35 23 24 3 25 7 25 35 45 2 2002.9 4 1925 2003 1997 8 1975 25
平成25年度調理師試験問題
25 15 60 HB 2 1 1 2 36 1961 46 1971 56 1981 3 1991 3 4-1 - 5 6 7 8 6 2 12 31 1 15 1 15 4 15 4 15-2 - 9-3 - 10 11 12 13 3-4 - 14 腿 15 16 WHO 22 2010 17 18 1-5 - 19 1 g 4 kcal 4 kcal 9 kcal 9 kcal 20 21
<4D F736F F D2090AC906C DCE88C88FE382CC91DE90458BCE984A8ED2816A8E9589C895DB8C B92B28DB82E646F63>
55 19 3 31 1 17 ( ) 1 55 CPI Community Periodontal Index ( 2)50 3,4 50 50 60 55 55 70 73 ( 59.0 2.8 ) ( 60 ( 59.0 2.5 ) 13 ( 59.7 4.3 )) ( 18) 2 ( 19) WHO 4 CPI SPSS 13.0J( ) 18 2 1 1 60 26.4 5.1 0.5 1.3
2
D 1 2 3 XX XY ( ) 4 5 GID ( ) ( ) ( ) ( ) WHO( ) ( ) ( ) WHO ( ) WHO ( ) 6 7 8 9 X Y XX XY XO XXY XXXY Y Y SRY Y SRY X XX XY SRY XY XX Y Y X Y Y DNA DNA 10 XY XY 11 12 13 F M T 14 U H R 15 K N F 16 M T
1 2 GDP GDP 1 31
GDP 1 0.4645 GDP 0.0771 1 1 0.315 1 0.1277 GDP 1 2 1 ⁰) 1 Elamin 1000 0.95 1 1 ) 1 G V Gill 1 AIDS ) 1 1 30 1 2 GDP GDP 1 31 32 1 + ) + ⁴) 33 http://wwwdbtk.mhlw.go.jp/toukei/youran/data14k/2-84.xls ⁵)
untitled
1. 1 2. 2 3.,1995 3 223119 3.1,, 4 3.2 NTT,2003 5 mile,2003 4.,, 6 , 2001 22 126 7 9 34 22 22 8 (139) 8 6. 6.1,,,,,, 9 6.2a Who What Whom When How Where 3 4 5 4 8 8 4, 7 6,,,, 2 or 3 6.2NGO NGO Who What
日医雑誌第126巻第9号
[] HIV 4 sexually transmitted diseases 1975 WHO 12 3 2 5 3 1 1 4 3 40 1 1947 4 WHO 1975 STDsexually transmitted diseases STIsexually transmitted infection 5 STD 5 10 20 5 5 HIV STD RTIreproductive tract
健康づくり検討会報告書（素案）
26 3 1 2 3 4 5 6 7 12 13 14 15 揃 16 爺 17 18 揃 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 箸 47 48 蓬 49 蓬 50 蓬 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66
13_高さ制限
#'(!"#$)*56+,-./01 222'(3456789:%;?@A?BCD!"#$%& () () 1. 1.25 2.3.1.5 ()() " 1.25 1.5) 1.25 or 1.5 1! 5 2)! 3)!562 7 8 !13012 2.5m 5 1/5 1m 5m 1/5 1m 2m 1.2m 9 4)!6132 35m 10m 10... A B 2A35m 12 1322
BMI BMI
() () 2 QOL () () QOL 11 6 14 20 13.9 20 BMI 12 70 40 11 6 14 20 13.9 20 BMI 12 70 40 57.1 100 ) 1 100 1 250 11 11 430 315 73.3 494 247 50.0 322 60 18.6 12 70 62 88.6 100 18 57.1 1 100 1 250 430 315 73.3
untitled
3 2) ( ) I ( ) 1) 16 ( : : ) 2) ( ) 1 ( ) 2 3 3 1. 2. 3. 4. ( ) 5. 6. TEACCH( ) TEACCH ( ) 10 ( ) 4 2 II 1) 1 2005 2 2004 2006 3 2003 12 1. 2. 3. 3 117 2006 4 ( ) 5 2) 1 2003 5 2 3) 1 ( ) 1998 2 3 4 NIPPON
Microsoft Word - aphj_slides pptx
1 99.2 10 98.5 10 15 95 20 2 24 U1RNP 140 90 3 100 20 25 4 5 WHO 6 10 20 10 10 15 7 10 1990 2000 2009 WHO 20 1990 8 11 0.002 10 10 20 10 12 9 13 MCTD 10 20 60 10 14 10 40 / 11 15 16 %VC FEV 1 COPD DLCO
NVX-Z555
-637-535-03 () HDD AV HDD AV NVX-Z555 005 Sony Corporation z z z 3 >. 3 3 z 3 z 3 z 3 4 3 3 4 4 5 3 3 4 z 4 5 - - 3 3 3 4 3 3 4 z Vv 3 4 V v B b V v B b 3 Vv 4 3 3 4 5 Vv 5 5 6 3 3 4 3 3 . 4.
1 th 1 th Dec.2006 2 1 2 3 1 2 3 2
1 th 1 th Dec.2006 2 1 2 3 1 2 3 2 1 th 1 th Dec.2006 1 2 3 4 1 2 3 4 3 1 th 1 th Dec.2006 13 13 4 1 th 1 th Dec.2006 5 1 th 1 th Dec.2006 1 1 2 3 3 9 6 1 th 1 th Dec.2006 EU 152 14 7 3 300 ( ( ( ) ) 17
Trans-Net Japan Trans-Net Japan Trans-Net Japan Boys don t cry TNJ F TNJ TS TS Trans-Net Japan Trans-Net Japan WHO FtM MtF FtM MtF FtM MtF MtF FtM FtM FtM MtF TS TS TS OK TS TS TG
untitled
1 2008 2008 9 2 2007 2008 2020 2020 3 2008 9 3 4 2020 4 1 2020 2 3 2020 4 1 2020 2020 2020 2 5 3 2020 2020 2020 2020 2020 4 2020 6 2 OB 2007 14 7 2020 2020 2020 14 8 2020 3 1 2020 1 2020 2 NATO 2020 NHK
untitled
2 3 4 5 1 RC 100 2000 2005 6 5 1 5 100 190 4 2000 YMCA 2003 2005 RC YMCA 100 3040 3 RC 2000 WCSRI 2660 WCS RC WCS YMCA 100 2000 4 RC RC YMCA RC 20002001 WCS 2 2001 2 10 14 RC WCS 3,300 38 1 YMCA YMCA 3
CONTENTS 2
The Available Solution Cat.No. C2006-2 CONTENTS 2 3 5 6 7 8 9 10 T 11 12 13 1 15 16 r R R 17 18 12 1 q w 1 19 2 1 2 3 1 2 3 1 2 3 1 2 3 2 1 2 3 1 2 3 1 2 3 1 2 3 20 13 1 2 3 12 21 22 3.98 3.8 3.2 2.90
untitled
28 20 1 31 4 2 25 1 IgG IgA IgM IgE IgM 2 60 80 70 60 60 40 20 80 35 45 kg 150cc 100 120cc 100cc 30 40cc 7,000g 500cc 120cc 120 5=600cc 600g 30 2,100cc 1,000cc 3 4 14 5 6 7 8 9 10 11 12 SIDS SIDS SIDS
P3 P4 P6 P7 P11 P12 P14 P15 P16 P20 P22 P24 P28 P29 P30 P31 P32 P33 P9 2
1 P3 P4 P6 P7 P11 P12 P14 P15 P16 P20 P22 P24 P28 P29 P30 P31 P32 P33 P9 2 https://cs-web.osaka-u.ac.jp/menjo/ / in-coming freshman (who will enroll in Osaka University in October 2015) / The person who
untitled
. A B C D E F G H H N H N WHO H N WHO http://www.mhlw.go.jp http://idsc.nih. go.jp http:// homepage.nifty.com/sannk AFP http://www.afpbb.com http://www.dh.gov.uk context WHO good decision making A B
untitled
1998 6 25 ( ) 1 10 1982 10 28 37/7 1990 12 14 45/94 (WHO) 1 1989 12 8 NGO (ECE) 3 1995 10 25 ECE 1991 2 25 1992 3 17 1998 6 4 1 2 1. 2. a b c (a) (b) d 17 3. a b (a) c (b) 4. 5. 3 1. 2. 3. 4. 5. 6. 7.
諸外国における妊娠・出産等に関する情報提供事例収集 2
樽 1. WHO 2012World Health Statistics 2012 32 2.1 Centers for Disease Control and Prevention; CDC 33 20091544 1,000 102.1 12302 636 9413 1115 2108 7 1990200930 30 30 19755 201026 34,35 12 1990,2000,2009CDC/NCHS
精神障害者ホームヘルプサービスにおける教育の充実化
1987 62 1993 1999 11 2002 14 1999 11 2002 14 12 7 2 1 disease impairment disability handicap WHO 1980 1999 11 1,530 4,020 2002 14 1995 1998 2 10 2000 12 2003 15 1991 1994 51 1997 1998 10 3,261 ⑴ 3 p.82
8
7 8 9 1 1-1 1-2 2002 1 2000 10 1-3 2002 2 2000 11 2 3 WHO19951979 19952002p.47 4 22 5 12 2-1 18681919 6 1965 13 2-2 19201945 14 15 2-3 19461960 7 16 17 2-4 19611979 GDP 18 1956300 2,000 1960 11 1972 231006
untitled
c OR 21 OR 1. 21 21 IoT OR OR OR 260 8672 1 8 1 OR 2. 2.1 public health [1] communicable (infectious) diseases vehicle burden HIV/AIDS (SARS) 258 60 Copyright c by ORSJ. Unauthorized reproduction of this
untitled
230 1985 17 2002 2006 8 2007 9 2010 3 1 2 6,000 3 2007 9 2008 7 2009 7 10 2008 7 2009 7 2009 10 1 2004 4 6 3 2005 77 Medical polis 4 21 2006 3 2004 9 15 2004 2005 2006 2 4 3 1 2 1 60 8 108 100 100 1 100
. 1 EBM Evidence-Based Medicine JCAHO 2
1 1 . 1 EBM Evidence-Based Medicine JCAHO 2 . 2 3 . 4 . 5 . When Where Who What Why How 6 . 7 3 DPC . 20 30 8 20 30 . (1) 9 3 BP mm mm . (2) 10 . http://epath.medis.or.jp/ 11 . 12 . 13 . 14 15 . PDCA Plan
橡核の軍事利用と商業利用(2).PDF
(2) (1) 1952 12 12 1957 10 10 14 (2) 1961 1 3 SL-1 3 2-3 1966 10 5 (3) 1979 3 28 1981 3 8 1-4 3 (4) 1986 1 6 1986 4 26 31 30km 13 5 4 320 kw 100 kw 1983 12 (5) 1995 12 5 1997 3 11 8 35 1999 9 30 JCO 2
9 10 21 4 23 3 24 11 2012 24 5 28 4
9 10 21 4 23 3 24 11 2012 24 5 28 4 1 2 3 4 5 6 7 8 9 1 2 3 4 10 11 12 13 14 15 16 SIDS 17 18 19 20 21 22 1 2 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 1 2 3 4 5 6 01 3 4 P1 P P 10 11
Roosevelt After Inauguration *1 *2 2005 5 8 *1 c 1979 William S. Burroughs *2 c 1996 http://cruel.org/.. i 1 1 2 5 3 9 4 13 17 1 1 2 1 FBI 3 5 2 6 2 7 9 3 10 3 I SM 11 12 3 13 4 14 4 ACT 15 ACT ACT
香港
FTA CEPA 1970 1980 1980 51 1999 1998 24 2000 2007 2006 11 52 1999 FTA FTA FTA 2001 11 WTO WTO FTA FTA 53 FTA CEPA FTA WTO FTA CEPA 2000 FTA FTA 2000 17 FTA 2000 11 WTO 2000 FTA WTO FTA FTA FTA FTA 2001
arakidonsan.rtf
DHA (ARA) ARA DHA 50 DHA 20 DHA( ) γ 300 mg 170 mg 150 mg 78 mg 57 mg 3,200 mg 2,300 mg 1,700 mg 1,700 mg 1,700 mg β- E FAO DHA( ARA) DHA 2ARA 1 DHA 70mg 100g 35mg 100g 6 6 63 EPA DHA 63 6 EHA DHA 50 WEB
NEWS LETTER No.10 (Page 1)
Who When Where What Why How Who When Where What Why How U.S. Department of Agriculture / U.S. Department of Health and Human Services Guide Line PEOPLE'S REPUBLIC OF CHINA GUIDE LINE NORWAY WHO WHEN WHERE
AJISAI10-1.PDF
Vol.10,No.1,2001 Jan.2001 Vol.10 No.1 *1 50 10 30 DDT 1980 200 Sarcoptes Scabiei var 0.330.35mm 0.25 Hominis 0.35mm 2/3 1mm 4 1 Vol.10,No1,2001 4 1040 2mm 23 20%KOH 1 13 34 6 2 1417 8 4 1014 45 1025 10
2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 10mSv 15 16 17 4.46 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 3.8 2.07 2.91 1.37 2.3 1.31 1.84 1.56 1.2 1.33 2.03 0.5 1000 4000mSv 1000 4000mSv Preston et al. Radiat Res 168: 1 64,
Contents 1 4 Section Column Section
Contents 1 4 Section1 7 8 16 23 34 40 Column Section2 47 48 58 64 70 Section3 75 76 82 88 Interview Interview 94 96 Prologue Prologue Section 1 1 8 9 Section 1 10 1 19.8 19.1 17.4 14.6 16.0 16.9 48.7
1937 100 Q&A Q A 6 6 Q&A Q A EBM Q &A Q A 1 100 1 0 Q A WHO 1978 6000 1 2 17. 106 109, 2005., 1998 Q&A Q A C 1986 2 Narrative Based Medicine NBM NBM Q A Q: A 38 AT MD DO DO 1890 DD 2002 2007 3 2007
熱中症－２.PDF
Vol.14,No 56 Aug.2005 Vol.14 No.4 1960 27 65 1 60% 40% 7080% 50% 40% 15% 5% 2 Vol.14,No. 40% 15% 5% 142 144 15 4 4 150 5 2.5 2 3 1.5 27 154 152 194 103 114 1 27 30 10 2 2 100 1 1 20 5 5 16 0 63 154 152
JOMF-ｷｯｽﾞﾈｯﾄQ&Aﾌﾞｯｸ
Q&A Q&A A B Hib Hib DPT A MMR A MMR M measles M mumps R rubella MMR MMR MMR MMR MMR A BCG BCG BCG BCG BCG BCG BCG BCG BCG BCG BCG BCG BCG A A WHO A A B C D E A B A B B s DPT B B B A Vi A A O A
FELTCOVER.ai
OWNERS MANUAL OWNERS MANUAL www.riteway-jp.com FOR YOUR SAFETY AND CONFORT, IF YOU ARE ALIEN WHO LIVE IN JAPAN, PLEASE ASK SOMEONE WHO UNDERSTAND THIS MANUAL TO MAKE DETAILED EXPLANATION FOR YOU. MINIMUM
橡00論点公開表紙2000.PDF
1 2 3 4 Information Technology 5 6 7 CS 5332 ( 9 ), 1000 1 2 3 1 2 3 1 2 (b) Polluter Pays PrinciplePPP WHO Dual System Deutschland Grnerpunkt ,,, Management
2003 9 9 13 30 17 00
2003 12 2003 9 9 13 30 17 00 youkoinoue@cc.nara-wu.ac.jp 50 1954 tetsukubota@hotmail.com 1973 hshimizu@jikei.ac.jp 1941 mtanaka@fmu.ac.jp 1936 hirate@arch.t.u-tokyo.ac.jp 1954 masao@sic.shibaura-it.ac.jp
3 3 vision scenario
2 GE 3 3 vision scenario 4 1 4 C A C A C D G A G A C D G D G D D> 3 3 3 2 ( ) ( ) 5 3 IBM SFC 4 4 Vision Vision Vision ( ) ( ) ( ) ( ) ( ) 3 3 ..etc 4 2 4 M 3 3 3 ( ) NRI Web 40 100 1983 900 90% 18% ESOP
設置の趣旨等を記載した書類
232011 4 ... 1... 4... 5... 5... 9... 9... 11... 12... 12... 14... 14... 15... 15... 19 161639 8 8 1 9 1 61994 4 122000 4 2 142002 4 15 2003 4 192007 4 20 172005 4 100 1,000 510 172005 222010 1 192007
P3 P4 P6 P7 P11 P12 P14 P15 P16 P20 P22 P24 P28 P29 P30 P31 P9 2
1 P3 P4 P6 P7 P11 P12 P14 P15 P16 P20 P22 P24 P28 P29 P30 P31 P9 2 https://cs-web.osaka-u.ac.jp/menjo/ / in-coming freshman (who will enroll in Osaka University in April 2016) / The person who enrolled
在外教育施設派遣教員安全対策資料 在外教育施設派遣教員安全対策資料
1. 1. 1.1.1. 1.1.2. 1.1.3. 1.1.4. 1.1.5. 1. 2. 1. 3. 1. 4. 1-1 1-2 1-3 2. 1. 2. 2. 2. 3. 2. 4. 2.4.1. 2.4.2. 2-1 2. 5. 2. 6. 2.6.1. 2.6.2. 2.6.3. 2.6.4. 2.6.5. 2. 7. 2.7.1. 2.7.2. 2.7.3. 2.7.4. 2. 8. 2.
›Áfi¡ŒÎ“F’æ’¶
Shigetaka KATOW 2002 12 13 2 CDC Centers for Disease Control and Prevention CDC TV Dr. Julie L. Gerberding CDC 1 2001 9 11 2001 7 3 2 TV 60 2009 2 1 3 50 30 1976 1 5 BC1157 1 DNA DNA RNA 0100-0006 - -
1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) 10 10 1997( 9) 10 1996( 8) 12 5 2000( 12) 12 2002 14 3
1 20 1948( 23) 12 10 3 ( )* 1993( 5) 1994( 6) 1995( 7) 2004( 16) 10 10 10 * 1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) 10 10 1997( 9) 10 1996( 8) 12 5 2000( 12) 12 2002 14 3 * 2003 15 10 2 HIV* * 1997(
% ORG/WIKI/FILE:SALKWS.JPG 1. ORG/WIKI
3 3.1 世界的なポリオ根絶 67 3, 7 8 1789 19 19 198 55. 8. HTTP://WWW. POLIOERADICATION.ORG/ POLIOANDPREVENTION. ASPX 1931 19511233 1949 3 55 7. HTTP://UPLOAD.WIKIMEDIA.ORG/WIKIPEDIA/ COMMONS/5/5C/POLIO_EGYPTIAN_STELE.JPG.
untitled
DNA GDP GDP Brooks Adams, America s Economic Supremacy, 1900 BRICS WHO pain TV ABC SSRI GM GM IT IC INDIACHINA WHO GDP WHO OECD GDP WHO, World Health Report 2000, OECD Health Data 2003. GDP OECD GDP OECD
1 Copyright 2009 INFOCOM CORPORATION All rights reserved.
/ 3.1 0 Copyright 2009 INFOCOM CORPORATION All rights reserved. 1 Copyright 2009 INFOCOM CORPORATION All rights reserved. H1N167 http://www-bm.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou04/ 2 Copyright
23 12 16 ... - 1 -... - 3-1... - 3 -... - 3 -... - 3 -... - 3 -... - 4 -... - 6 -... - 9 -...- 11 -... - 14 -... - 14 -... - 14 -... - 14 -... - 15 -... - 15 -... - 16 -... - 17 -... - 17 -... - 17 -...
容 1 教 大 学 総 合 研 究 所 紀 ~J.11H11r 勿 論,~ 命 倫 理 に 関 する 諸 問 題 について,あるいは 終 末 期 医 療 の 現 場 で 諸 宗 教 が 果
/ 123 / 30 7/ / 78 9/ / / 40 2/ / 150 2/583/ / 40 3/ /8 6 1/29
/ 123 / 30 7/2529 5 10 3 2 / 78 9/81215199 2226 6 9/71214219 28 5 3 1 / 40 2/2022 3 1 4/ 150 2/583/18 1516 6 1 / 40 3/2628 10 10 6 6 8/8 6 1/29 40 1/2023 2 4 12 7 14 10 2/20 2/23 3 3 ( ) 2/29 B 10 10 2
- March vs..
GDP. - March vs.. GDP - March GDP PPP GDP - March. GDP. BRICs IMF GDP. BRICs GDP >.. GDP / GDP governance / SARS - March NGO SARS. - March . WHO WHO / - March.. UNDP. GDP GDP. WTO. - March cool. WTO.
16
16 ...1...2...3...5...6...6...6...7...8...9...10...10...11...12...12...13...15...15...16...17...18...19...20...21...21...22...23...24...25...25...26...28...30...31...32...33...33...34 ...35...36...37...38...39...40...40...40...40...40...40...40...41...41...41...41...42...42...42...42...43...43...43...44...44...44...44...45...45...45...46...46...46...47...47...48...49...50
01_31窶愴胆1窶窶ｰ窶慊ｲfiﾂ｡01-16
157 YAMADA Sohei0 1999 1999 JR JR 158 JR JR JR 800 11 1698 53 21 26 459 33 159 1993 160 1948 1997 JR 100 1321 1873 2001 161 33 13 162 13 53 1734 10 11 12 13 14 163 15 16 164 17 18 19 20 21 22 165 23 166
untitled
1998 10 9 3 8 2010 6 13 SSKU 3510 SSKU http://www.circle-echo.com/ 2 4 5 6 9 11 1998 10 9 2010 6 13 SSKU 3510 WHO 20 5 20 25 11 3 2 1998 10 9 2010 6 13 SSKU 3510 TKK 2003 NPO 13 12 1 3 3 3 1 OTPTST 2 VIVID
資料４ 「動物の愛護管理の歴史的変遷」
BC6 701 721 795 1685 1709 1835 1846 1849 1822 1824 1850 1854 RSPCA 1840 1865 1871 (M4) 1876 (M9) - 1 - 1892 (M25) 1895 (M28) 1896 (M29) 1897 (M30) 1898 (M31) 1899 (M32) 1902 (M35) 1903 (M36 1905 (M38)
Microsoft Word - 書籍リスト.doc
95.4 95. 6.10 95.12.20 96.2.17 96.2.19 96.3.1 96.3.10 96.4.1 96.5.1 96.6.1 96.7.1 96.8.17 35 96.9.1 96.9.10 15 PHS 96.9.28 96.10.1 1 96.10.14 96.11.1 96.11.21 96.11.21 96.11.27 96.12.1 96.12.1 96.12.10
IPSJ SIG Technical Report Vol.2013-IS-126 No /12/ CIO Examination of Strategic Decision Making for System Planning Phase Yukio Amagai
1 1 1 1 2 CIO Examination of Strategic Decision Making for System Planning Phase Yukio Amagai 1 Masato Yokota 1 Masahiro Ide 1 Ryuichi Harada 1 Hironori Washizaki 2 Decision making in such as a systemization
園田学園論文集 ４５号（よこ）☆／９．林谷，他
45 2011. 1 4 1 2 1 2 2007 17 9 1 7 9 2 3 4 5 614 2 1 2009 4 6 2 IC 3 4 PC 112 1 1 4 38 12 38.9 12 1.5 4 3 9 8 1 2 1 1 1 2 1 A 35 2 2 2 42 200 B 41 3 1 41 200 C 32 9 1.2 1 32 40 D 44 11 5 2 44 30 2 1 A
環境シンポジウム報告書「アスベスト被害 予防の現状と課題～建物に使用されているアスベスト問題～」
INDUST 3 1 2 3 1 2 1 5,000 1 1980 1 3 1 2 3 26 10 9 2006 1 2009 2 1 1 2 2 1 2 2 2 16 33 5 26 33 5 26 46 4 28 2 2 54 3 3,000 1,300 1 25 7 12 49 3 14 5 2 3 15 717 62 62 17 7 63 2 63 2 13 9 45 6,000 2 1 9-11
EXPLORING DISABILITY:A Sociological Introduction CASE MANAGEMENT AND SOCIAL WORK PRACTICE The Viewpoint of Disabled People Required for Home Helpers Who Support the Social Life of the Disabled Leading
HPV HPV HPV HPV 7 HPV 8 9 HPV 3 HPV HPV HPV , Becker Ajzen H
3 26 3 Journal of Junshin Gakuen University, HPV Faculty of Health Sciences Vol.3, March 2014 99 HPV Knowledge of and attitudes towards human papillomavirus vaccinations among mothers who have daughters
5 5.1 35
C: PC H19 A5 3.BUN 19 8 6 5 35 5.1............................ 35 5.2 1...................... 38 5.3 2...................... 39 5.4............................. 41 5.5 Thevenin................. 46 5.6.....................
A guide of facilitation for Design Thinking 100 No.2 3 2 Ideate Prototype & Test Demo (///) 2 10 ( /)
加藤茂孝先生
ooooooo oooooooooooooooooooooooooo 10 30 11 oooooooooooooooooooooooooo Shigetaka KATOW ooooooo 1 1 1 100 1 1 3 2003 SARS SARS 9.11 2 2 30 2003 SARS 2009 200 SARS 1 2001 0101-0051 - RIKEN Center of Research
加藤茂孝先生
Shigetaka KATOW 2009 4 24 WHO 5 9 1 5 16 1 TV 6 12 6 11 WHO 6 4 5 12 E-mail : modern_media@eiken.co.jp 2009. 4. 28. http:idsc.nih.go.jpidwrkanjaweeklygraph01flu.html 0101-0051 - RIKEN Center of Research
2
1 2 3 4 5 ( ) 6 7 8 "proteinaceous infectious particles" ( ) (PrP Sc ) (PrP C ) PrP C PrP Sc PrP Sc 9 10 (1) (2) 11 12 13 14 15 16 (1) (2) (3) 17 (4) (5) 18 19 20 21 22 23 24 (1) Creutzfeldt-Jakob - -.
The Heart Healthy Tocotrienol Complex Tocomin SupraBio
The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation
(1) 5 (2) VNTR IS6110RFLP, VNTR35loci JATA(12) JATA(12) MIRU(12) Supply(15) (3) INH inha 22 (4) 5 5 INH RFP 95% 90% 90% 11 (5) 5
(1) 5 (2) VNTR IS6110RFLP, VNTR35loci JATA(12) JATA(12) MIRU(12) Supply(15) (3) INH inha 22 (4) 5 5 INH RFP 95% 90% 90% 11 (5) 5 (6) 30-50 2006 MDR 97 XDR 43.3 15-optimized MIRU VNTR 17 gralnulysin 15k
0228.indd
... 3... 4... 6... 10... 18... 22... 30... 37... 46... 53 2 G HIV HIV WHO AIDES NGO 3 4 5 6 7 8 9 10 11 12 13 HIV/ 14 HIV HIV HIV/ HIV 15 16 17 18 19 20 21 22 23 24 25 26 27 G 28 1 HIV HIV 29 30 31 32
Ⅰ.WhO の 長 期 転 帰 研 究
総 説 索 引 用 語 は じ め に Ⅰ.WhO の 長 期 転 帰 研 究 Ⅱ. 病 院 ベースの 転 帰 研 究 Ⅲ.コミュニティベースの 転 帰 研 究 Ⅳ. 死 亡 率 謝 辞 ま と め 文 献 Powered by TCPDF (www.tcpdf.org) Outcome of Schizophrenia in Asia:From the Viewpoint of Comparison
: No S /30 S /23 S /12 1 S S /304/12 S-6 5 S /12 1 S /12 2 S-9 2
36 5 5.1 5.1.1 1998 2008 1998 10 1988 S-4610 19 5.1S-3 S-1314 S-1 S-2 S-3 S-5 S-7 1998 2 S-8 S-9 S-10 2007 2008 S-12 S-1314 5.1 37 5.1: 1998 2008 2008 No 1998 2008 S-1 2 2 3/30 S-2 12 7 3/23 S-3 2 0 4/12
座談会/2009
6 2008 10 3 9 2008 2 9 Asian-African Research Network 4 A preliminary experiment of Japan over these four years05 08 1900 2000 50 3 50 3 1969 Surgeon General William T. Stewart 2003 SARS SARS 2003 2 M
小児感染免疫第23巻第1号
Vol. 23No. 163 42 HPV HPV 1113 HPV 42 HPV HPV HPV 1 1 510 1020 HPV 1020 510 HIV 0.1 0.005 HIV 2030 HIV 0.2 510 HPV 1020 15 HIV 2030 HIV HIV 0.2 0.1 Takeyuki Sato 2608677 181 64 2011 2 1 1518 6,000 513
UT_layout_0718_プレス用修正.indd
03 31 37 07 108 12 13 14 15 2 100 & 17 3 28 I03 I I 80100 2007 100 2014 2017 UT CEO 1995 20 05 UT Campus for H UT Campus for H 2 04 UT 2014 Campus for H CEO UT Campus for H 07 I 1 I 1 2010 1992 H 09 ONOFF